California state-funded institute scraps selection process that put cancer projects at a disadvantage Cancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

On June 9, the House Appropriations Committee passed its version of the fiscal year 2027 spending bill for Labor, Health and Human Services, and Education.

NIH calls for comment on proposal to limit the number of RPGs per PI

NIH has published a request for information on its proposed policy that would cap the number of research project grants, or RPGs, for which an individual can simultaneously serve as principal investigator or multi-principal investigator.

Stanford Medicine proposes building an integrated care and research center in Redwood City

Stanford has unveiled plans to build an integrated clinical care and research center in Redwood City, CA. The institution plans to submit its formal updated project description to the city and host informational community webinars.

June 12, 2026

Vol.52 No.23

In Brief

NCI selects UChicago Medicine as a lead site for clinical trials

The University of Chicago Medicine Comprehensive Cancer Center has been granted a six-year, $5 million grant from NCI.

June 12, 2026

Vol.52 No.23

Clinical Roundup

Tafasitamab + lenalidomide and R-CHOP improves PFS, phase III frontMIND trial finds

The phase III frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi/Minjuvi), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma or high-grade B-cell lymphoma, has produced positive results.

June 12, 2026

Vol.52 No.23

Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final

The White House Office of Management and Budget has released a 412-page proposal that inserts political appointees into all stages of reviewing and awarding of federal research grants.

June 05, 2026

Vol.52 No.22

By Paul Goldberg and Claire Marie Porter

California state-funded institute scraps selection process that put cancer projects at a disadvantage

Cancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

YOU MAY BE INTERESTED IN

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

NIH calls for comment on proposal to limit the number of RPGs per PI

Stanford Medicine proposes building an integrated care and research center in Redwood City

NCI selects UChicago Medicine as a lead site for clinical trials

Tafasitamab + lenalidomide and R-CHOP improves PFS, phase III frontMIND trial finds

Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final

Renew today!

Subscriber content

Never miss an issue!

Login